Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
10%+ Owner
-
Issuer Symbol
-
LTRN on Nasdaq
Aaron G.L. Fletcher - trading volume in the past year for Lantern Pharma Inc.
Holdings reported by Aaron G.L. Fletcher for Lantern Pharma Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
373,178 |
$1,153,120 |
$3.09 |
13 Jun 2025 |
By Bios Fund II QP, LP |
|
|
| Common Stock |
323,335 |
$999,105 |
$3.09 |
13 Jun 2025 |
By Bios Fund I, LP |
|
|
| Common Stock |
189,117 |
$584,371 |
$3.09 |
13 Jun 2025 |
By Bios Fund I QP, LP |
|
|
| Common Stock |
114,272 |
$353,100 |
$3.09 |
13 Jun 2025 |
by Bios Fund II, LP |
|
|
| Common Stock |
49,957 |
$154,367 |
$3.09 |
13 Jun 2025 |
By Bios Fund II NT, LP |
|
|
| Common Stock |
26,093 |
$100,718 |
$3.86 |
13 Jun 2025 |
By BP Directors, LP |
|
|
Transactions reported by Aaron G.L. Fletcher for Lantern Pharma Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.